Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Zilli

Showing results (191-200 of 234) with videos related to

Pageof 24
Sort By:
European Urology Oncology|November 8, 2025
Radiotherapy plus Long-term Adjuvant Androgen Deprivation with a Luteinizing Hormone-releasing Hormone Antagonist Versus Agonist in Patients with Very High-risk Localized or Locally Advanced Prostate Cancer: The EORTC GUCG-1414 Phase 3 Randomized TrialThomas Zilli, Dirk Böhmer, Andreas Roeder, et al.
Journal of Neuroinflammation|October 29, 2025
TSPO contributes to neuropathology and cognitive deficits in Alzheimer's diseaseKelly Ceyzériat, Aurélien M Badina, Laurene Abjean, et al.
European Urology Oncology|February 11, 2026
Prognosis and Treatment Response in Aggressive-variant Prostate Cancer and Treatment-related Neuroendocrine Prostate Cancer: A Systematic Review and Meta-analysisMartino Pedrani, Giuseppe Salfi, Giovanna Pecoraro, et al.
European Urology Oncology|May 18, 2026
The Diagnostic Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Patients with Rising PSA After Radical Prostatectomy and Postoperative Radiotherapy: A Systematic Review and Meta-analysisDonato Cannoletta, Elio Mazzone, Francesco Di Bello, et al.
Clinical Genitourinary Cancer|July 12, 2024
Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future PerspectivesFabio Turco, Consuelo Buttigliero, Marco Donatello Delcuratolo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 9, 2025
Radiotherapy quality assurance for the PEACE 1 trial: An individual case review analysisNajlaa Alyamani, Enrico Clementel, Paul Sargos, et al.
Prostate Cancer and Prostatic Diseases|September 12, 2024
Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysisAkihiro Matsukawa, Takafumi Yanagisawa, Tamas Fazekas, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2020
Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 TrialMaud Jaccard, Thomas Zilli, Angèle Dubouloz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2018
Clinical impact of <sup>68</sup>Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introductionJulian Müller, Daniela A Ferraro, Urs J Muehlematter, et al.
European Urology|January 21, 2025
The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer CareVedang Murthy, Giulia Marvaso, Barbara A Jereczek-Fossa, et al.
Pageof 24

Showing results (191-200 of 234) with videos related to

Sort By:
Pageof 24
European Urology Oncology|November 8, 2025
Radiotherapy plus Long-term Adjuvant Androgen Deprivation with a Luteinizing Hormone-releasing Hormone Antagonist Versus Agonist in Patients with Very High-risk Localized or Locally Advanced Prostate Cancer: The EORTC GUCG-1414 Phase 3 Randomized TrialThomas Zilli, Dirk Böhmer, Andreas Roeder, et al.
Journal of Neuroinflammation|October 29, 2025
TSPO contributes to neuropathology and cognitive deficits in Alzheimer's diseaseKelly Ceyzériat, Aurélien M Badina, Laurene Abjean, et al.
European Urology Oncology|February 11, 2026
Prognosis and Treatment Response in Aggressive-variant Prostate Cancer and Treatment-related Neuroendocrine Prostate Cancer: A Systematic Review and Meta-analysisMartino Pedrani, Giuseppe Salfi, Giovanna Pecoraro, et al.
European Urology Oncology|May 18, 2026
The Diagnostic Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Patients with Rising PSA After Radical Prostatectomy and Postoperative Radiotherapy: A Systematic Review and Meta-analysisDonato Cannoletta, Elio Mazzone, Francesco Di Bello, et al.
Clinical Genitourinary Cancer|July 12, 2024
Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future PerspectivesFabio Turco, Consuelo Buttigliero, Marco Donatello Delcuratolo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 9, 2025
Radiotherapy quality assurance for the PEACE 1 trial: An individual case review analysisNajlaa Alyamani, Enrico Clementel, Paul Sargos, et al.
Prostate Cancer and Prostatic Diseases|September 12, 2024
Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysisAkihiro Matsukawa, Takafumi Yanagisawa, Tamas Fazekas, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2020
Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 TrialMaud Jaccard, Thomas Zilli, Angèle Dubouloz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2018
Clinical impact of <sup>68</sup>Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introductionJulian Müller, Daniela A Ferraro, Urs J Muehlematter, et al.
European Urology|January 21, 2025
The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer CareVedang Murthy, Giulia Marvaso, Barbara A Jereczek-Fossa, et al.
Pageof 24